Henry Schein (NASDAQ:HSIC) Releases Earnings Results, Misses Expectations By $0.04 EPS

Henry Schein (NASDAQ:HSIC) announced its earnings results on Tuesday. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04), Zacks reports. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein updated its FY 2025 guidance to 4.800-4.940 EPS.

Henry Schein Trading Up 0.5 %

Shares of NASDAQ HSIC opened at $77.64 on Tuesday. The business has a 50 day simple moving average of $74.19 and a 200 day simple moving average of $72.38. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.63. The stock has a market cap of $9.68 billion, a price-to-earnings ratio of 31.95, a PEG ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Wall Street Analyst Weigh In

HSIC has been the topic of several analyst reports. Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Mizuho initiated coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Barrington Research increased their price objective on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Eight research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Henry Schein has an average rating of “Moderate Buy” and an average target price of $80.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.